Fairchem Organics share price today

Fairchem Organics Ltd's share price was ₹681.45 at the close on 4 November 2026. It has been stalling near its high for 4 weeks. That is 0.6% below its average price over the last 200 trading days. Over the past 13 weeks it has done worse than the NIFTY 500, and it has been behind for 2 weeks running.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). Today Fairchem Organics Ltd is in stage 3. The phase helps read everything below.

In the last 52 weeks it traded between ₹457 and ₹797, and at that close it sat 66% of the way up from that low.

Over the last 5.9 years the share price moved +5% while the NIFTY 500 moved +90%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 23 October 2026. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

2 points on a year earlier.

1. Indian funds and insurers (DIIs) cut their stake for 5 quarters in a row

   From 5.8% to 1.4% of the company by the September 2026 quarter.

2. Operating margin up 6.2 points on a year earlier

   10% in the September 2026 quarter, from 3.8%.

   Why: Margins rose because raw materials cost less and the company sold finished products at higher prices.

   Next results: check whether margins hold, since management said it is confident to maintain them if conditions stay as they have been over the last 6 months.

   From the earnings call on 23 Oct 2026.

For July to September 2026 (the quarter ended 30 September 2026), Fairchem Organics reported revenue of ₹167 crore, up 49.1% from ₹112 crore a year earlier, and a profit of ₹10.0 crore, up 900.0% from ₹1.00 crore.

Fairchem Organics results: July to September 2026 against a year earlier

The next results, for October to December 2026, are due by 14 February 2027: listed companies must publish quarterly results within 45 days of the quarter's end (60 days for the January to March quarter).

Fairchem Organics' management discussed these results on a call held on 23 October 2026; what it said is further down this page.

From the company's reported quarterly results (quarter ended 30 September 2026). Revenue and profit in ₹ crore.

Fairchem Organics closed at ₹681.45 on 4 November 2026, down 7.7% from ₹738.45 a year earlier (7 November 2025) and down 65.7% over five years. Its highest weekly close since December 2020 was ₹2,217.00 on 14 October 2022.

Fairchem Organics share price: then and now

Weekly closing prices. Each change is the move from that price to the 4 Nov 2026 close. A day's intraday high or low can go beyond these weekly closes.

313 weekly closes from 24 December 2020 to 4 November 2026.

4 Nov 2026: Fairchem Organics closed at ₹681.45, up 7.1% on the week and up 3.0% on the month. 23 Oct 2026: Fairchem Organics held its results call for July to September 2026. Management guided: Current operating margin to be maintained, with further improvement pursued.

Earlier

• Results for July to September 2026: Revenue up 49.1% and profit up 900.0% on a year earlier.
• 20 Jul 2026: ex-date for a dividend of ₹1 a share.

Fairchem Organics paid ₹1 a share in regular dividends in the 12 months to 5 November 2026 (1 payment), a yield of 0.15% at the ₹681.45 close on 4 November 2026. The last was a dividend of ₹1 a share, ex-date 20 July 2026.

Fairchem Organics dividends since 1 April 2021

Amounts as the company declared them on the NSE. A dividend goes to whoever owns the shares before the ex-date. The record date is the same day as the ex-date for every payment here.

Not in its latest year. Fairchem Organics Ltd paid out 0% of its profit as dividends in FY26. It did pay a dividend in 5 of its last 7 reported years, so there is a history but no current dividend.

From the NSE corporate-actions record, read 5 November 2026.

“We are confident that we will be able to maintain this if the situation remains as it has been over the last 6 months.”Nahoosh Jariwala, Managing Director and Chairman, on the call for July to September 2026

What management guided

• Business growth of 5-10% each quarter.
• Capacity utilization to improve by 5% each quarter.
• Novel fatty-acid pilot expected to start operations in Oct-Dec, after Diwali.
• US exports expected to commence once freight stabilizes.

Management’s own plans and goals, from our notes of the call. A plan is not a result.

Source: the call transcript.

From the call for July to September 2026, 23 October 2026.

First: Sequential tonnage: check whether production growth resumes against the stated quarterly ramp.

Fairchem Organics is not on any of our India lists this week.

Fairchem Organics Ltd earned ₹10.0 Cr of net profit in the Sep 2026 quarter, +900.0% on the same quarter a year earlier. That is the 3rd quarter in a row of profit growth. Full-year FY26 profit was ₹6.0 Cr. Over 6 years profit has grown −25.5% a year on average. That is 6.0% of the quarter's revenue.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

The same quarter a year earlier earned ₹1.0 Cr.

For the full year, FY26 profit was ₹6.0 Cr (−72.7% on the year before).

Why profit moved: revenue changed +49.1% on a year earlier and the margin moved +6.2 percentage points. Most of the change came from keeping more of each sale.

On average over the last four quarters, profit changed +500.0% and revenue +17.0%. Profit is growing faster than sales: fixed costs are spread over more sales, so each extra rupee of revenue adds more to profit.

Fairchem Organics Ltd reported ₹167 Cr of revenue in the Sep 2026 quarter, +49.1% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 6 years it has grown 7.0% a year on average. The last full year, FY26, came in at ₹460 Cr.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to ₹560 Cr.

FY26 revenue was ₹460 Cr, −14.5% on the year before.

Recent pace: the last four quarters grew +17.0% on average, against 7.0% a year over the longer run, so this year is growing faster than its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +17.2%, against −4.4% a year over the last 8 quarters (accelerating); profit over the last 12 months grew +242.9%, against −24.4% a year (accelerating).

Fairchem Organics Ltd's operating margin was 10.0% in the Sep 2026 quarter, 6.2 percentage points higher than the same quarter a year ago. Across 7 years it has been between 4.7% and 17.0%. The latest quarter is within that range.

Operating margin is what is left from every ₹100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed +6.7 percentage points on the year while gross margin changed +4.2 points. So the gain came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 146% of Fairchem Organics Ltd's reported profit came in as cash from its operations, so the profit is backed by cash. In FY26 it brought in ₹42.0 Cr of operating cash against ₹6.0 Cr of profit. After ₹12.0 Cr of spending on assets, ₹30.0 Cr was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why 146% of profit came in as cash: the cash cycle got 48 days longer between FY21 and FY26, so more of each rupee of profit waits in the business before it arrives.

What to look at next: the bigger use of cash is spending on new assets, at 1.7× depreciation over three years. The next section checks what that spending is building.

Fairchem Organics Ltd's cash cycle, the days between paying suppliers and getting paid by customers, was 139 days in FY26, up from 91 days in FY21. It spent ₹54.0 Cr on assets over the last 3 years. Customers take 54 days to pay, and stock sits for 96 days on average.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

At FY26 sales of ₹460 Cr, each day of that cycle ties up about ₹1.3 Cr, so roughly ₹175 Cr is tied up in the business at any time.

FY26: customers took 54 days to pay and stock sat for 96 days, about 3.2 months of sales sitting as stock, for a full cycle of 139 days, longer than FY21's 91.

The full loop: cash goes out to suppliers and production on day 0. Stock sits for 96 days. Customers pay about 54 days after that. Suppliers are paid at 12 days. Together that makes the 139-day cycle.

Spending on assets: ₹54.0 Cr over the last 3 years, against ₹31.0 Cr of depreciation (the yearly wear and tear on existing assets). So it is building well beyond replacing what wears out. Work still in progress is ₹18.0 Cr (FY26): assets paid for that are not earning yet.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

Fairchem Organics Ltd's P/E is 35.0×, in the middle of its own history: higher than 38% of past readings. Its usual P/E (the middle reading) is 38.1×, over 5.8 years of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many rupees the market pays for each rupee of yearly profit.

The P/E here, and its history, use a profit figure that can leave out one-off items, so it can differ from a P/E worked out on the quarterly results. Those results' earnings per share for the four quarters to Sep 2026 add up to ₹18.87.

Why the multiple is where it is: over the past year earnings per share moved −73.9% while the price moved −7.7%. The price did better than earnings, which pushed the multiple up within its own range.

Where the price move came from: over 5 years the price moved −19.3% a year; about −19.6% a year came from earnings growth and about +0.3 percentage points from the multiple (roughly no change). The split is approximate (price return minus earnings growth). It shows how much of the move came from the market paying a different multiple.

In short: the multiple is about average against its own past, so the earnings trend underneath matters more than the multiple.

Fairchem Organics Ltd's business is getting better. EPS growth hit its low 3 quarters ago at −85.6% and has recovered to +306.7%, with ROCE steady at 3.9%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: a lasting rise from a low is what this page is built to show.

The latest quarter’s profit includes a one-off item bigger than the normal business, so the profit line is shown but does not count in this reading.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the share price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

Fairchem Organics Ltd earned a ROCE of 3% in FY26. Its return on capital used (ROIC) is 4.2 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 1.3% net margin and 1.18× asset turnover (sales divided by assets).

Return on capital employed (ROCE) is the profit the whole business earns on all the money in it, from shareholders and lenders together. It is the best single test of whether growth adds value or just size.

Why the return is what it is (FY26): a 1.3% net margin × 1.18× asset turnover × 1.49× leverage (assets divided by equity) ≈ 2.3% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 7.8% − 12.0% = −4.2 percentage points. The 12.0% is a standard assumption for the cost of capital in India, not an estimate for this company. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

The 7.8% ROIC above is the latest reading, as reported. The yearly chart below shows FY26 at 2.3%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method.

Fairchem Organics Ltd has total debt of ₹70.0 Cr against shareholder equity of ₹282 Cr as of Sep 2026, so its debt is 0.25× its equity, which is very little. Year by year, that ratio went from 0.27 in FY22 to 0.32 in FY26. So the returns on this page come from the business, not from borrowed money.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

Domestic institutions cut their stake in Fairchem Organics Ltd by 3.7 percentage points over 8 quarters, the biggest change among its owners. Domestic institutions now own 1.4% of the company. Promoters moved +2.0 points over the same period, to 63.3%. This uses the four owner groups that companies report every quarter; nothing is guessed between filings.

Who owns the company each quarter: promoters (the founders or controlling owners), foreign institutions, domestic institutions such as mutual funds, and the public. When people close to the business steadily raise their stake, that is worth noticing; a quiet list is also an answer.

Over the last two years: Domestic institutions: −3.7 points over 8 quarters, to 1.4%; Promoters: +2.0 points over 8 quarters, to 63.3%; Foreign institutions: +0.1 points over 8 quarters, to 6.4%.

Why the owners changed: domestic institutions drove it (−3.7 points), with the other side taken by promoters (+2.0 points). They reduced their stake.

For Fairchem Organics Ltd, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

53.3 out of 100, rank 10 of 20 in Chemicals - Organic, with 100% of the evidence available.

Fairchem Organics Ltd scores 53.3 out of 100 against the 20 companies it is compared with in Chemicals - Organic, ranking 10. Earnings are strong; relative strength in its sector is -15.4% and the one-year return is -15.9%.

The four parts add up to the total exactly: 30.3 + 7 + 13 + 3 = 53.3. This is the same number shown on the industry page; it is worked out once for the whole group and read here.

What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector.

Fairchem Organics ranks 10 of 20 Chemicals - Organic companies on the 4-Factor Sector Score, with 53.3 out of 100.

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led NIFTY 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read.

The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section.

Related companies: Chemicals - Organic, all 20 compared on one page.

Fairchem Organics is the 17th largest of 20 Chemicals - Organic companies on Sector Alpha by market value (scores of 30 October 2026). Just above it: Indo Amines, Valiant Organics and OCCL. Just below it: Shree Ganesh Remedies, Gem Aromatics and GFL.

Chemicals - Organic companies close in size

14. Indo Amines Ltd ₹865 crore
15. Valiant Organics Ltd ₹864 crore
16. OCCL Ltd ₹841 crore
17. Fairchem Organics Ltd ₹801 crore
18. Shree Ganesh Remedies Ltd ₹792 crore
19. Gem Aromatics Ltd ₹716 crore
20. GFL Ltd ₹568 crore

All 20 Chemicals - Organic companies, largest first

Companies close in size in other industries

1728. Metalic Technoforge Ltd ₹805 crore · IT - Software
1729. Likhitha Infrastructure Ltd ₹803 crore · Infra - Construction & Contracting
1730. Fairchem Organics Ltd ₹801 crore
1731. RNFI Services Ltd ₹800 crore · E-Commerce - Platform - Utility
1732. Manoj Vaibhav Gems N Jewellers Ltd ₹799 crore · Diamond, Gems & Jewellery